21:01 ETKaneka Intends to Appeal Invalidity Decision in Lawsuit Against CoCrystalprnewswire·Sep 9 at 01:05 AMCOCP+0.81%4118
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors | COCP Stock NewsStockTitan·Aug 17 at 07:17 AMCOCP+0.81%
Cocrystal Pharma Q2 FY26 net loss widens to $3.16 million; R&D expense climbs to $2.14 millionPUBT·Aug 13 at 11:31 AMCOCP+0.81%
OPKO Health, Inc. Discloses Investment in Cocrystal Pharma with 29.6% StakeTradingView·Aug 7 at 11:56 PMCOCP+0.81%OPK+5.37%
Cocrystal Pharma director Phillip Frost reports $9,816 common share purchasePUBT·Aug 6 at 09:26 PMCOCP+0.81%
The 2026 Market Fringes: AI Grifters, Reverse Splits, and A Few Real BusinessesGlobal Report·Aug 5 at 09:13 AMPI+2.93%EXPE+1.43%
From Crypto Pivots to AI Contracts: Niche Equities Reengineer Balance Sheets in 2026Global Report·Aug 4 at 09:17 AMSHPH0.00%VSEE+5.63%
Cocrystal Pharma sells 5,474,053 shares to OPKO in USD 5 million private placementPUBT·Aug 3 at 11:01 AMOPK+5.37%
Cocrystal Pharma Shareholders Approve Governance and Oversight MeasuresTip Ranks·Jul 17 at 12:28 PMCOCP+0.81%
